tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AVTX Stock Latest News

Avalo Therapeutics files $750M mixed securities shelf
The FlyAvalo Therapeutics files $750M mixed securities shelf
1d ago
AVTX
Avalo Therapeutics initiated with an Outperform at Mizuho
PremiumThe Fly
Avalo Therapeutics initiated with an Outperform at Mizuho
23d ago
AVTX
Avalo Completes Enrollment for Phase 2 LOTUS Trial
PremiumCompany Announcements
Avalo Completes Enrollment for Phase 2 LOTUS Trial
1M ago
8K
AVTX
Avalo Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Avalo Therapeutics Reports Q3 2025 Financial Results
2M ago
AVTX
Avalo Therapeutics reports Q3 EPS ($2.19), consensus ($1.64)
PremiumThe Fly
Avalo Therapeutics reports Q3 EPS ($2.19), consensus ($1.64)
2M ago
AVTX
Avalo Completes Enrollment for Phase 2 LOTUS Trial
PremiumCompany AnnouncementsAvalo Completes Enrollment for Phase 2 LOTUS Trial
2M ago
8K
AVTX
Avalo Therapeutics completes enrollment in Phase 2 LOTUS trial
Premium
The Fly
Avalo Therapeutics completes enrollment in Phase 2 LOTUS trial
2M ago
AVTX
Avalo Therapeutics Advances in Hidradenitis Suppurativa Treatment with AVTX-009 Study
Premium
Company Announcements
Avalo Therapeutics Advances in Hidradenitis Suppurativa Treatment with AVTX-009 Study
2M ago
AVTX
Oppenheimer healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Oppenheimer healthcare analysts hold an analyst/industry conference call
3M ago
AVTX
Avalo Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Avalo Therapeutics management to meet with Piper Sandler
3M ago
AVTX
Avalo Therapeutics Highlights AVTX-009 Potential in New Presentation
PremiumCompany Announcements
Avalo Therapeutics Highlights AVTX-009 Potential in New Presentation
3M ago
8K
AVTX
Avalo Therapeutics Strengthens Leadership with Key Appointments
PremiumCompany Announcements
Avalo Therapeutics Strengthens Leadership with Key Appointments
3M ago
8K
AVTX
Avalo Therapeutics appoints Boyd as CBO, Ivanowicz as SVP, Human Resources
PremiumThe FlyAvalo Therapeutics appoints Boyd as CBO, Ivanowicz as SVP, Human Resources
3M ago
AVTX
Avalo Therapeutics Appoints Kevin Lind to Board
Premium
Company Announcements
Avalo Therapeutics Appoints Kevin Lind to Board
4M ago
8K
AVTX
Avalo Therapeutics appoints Kevin Lind to board of directors
Premium
The Fly
Avalo Therapeutics appoints Kevin Lind to board of directors
4M ago
AVTX
Avalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
PremiumThe Fly
Avalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
4M ago
ABBV
AVTX
Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data
PremiumThe Fly
Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data
4M ago
AVTX
3 Best Stocks to Buy Now, 9/12/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 9/12/2025, According to Top Analysts
4M ago
AVTX
ENVX
3 Best Stocks to Buy Now, 9/5/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 9/5/2025, According to Top Analysts
4M ago
ET
AVTX
Buy Rating for Avalo Therapeutics Driven by Promising AVTX-009 Development and Market Potential
PremiumRatingsBuy Rating for Avalo Therapeutics Driven by Promising AVTX-009 Development and Market Potential
4M ago
AVTX
Avalo Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
Avalo Therapeutics initiated with a Buy at TD Cowen
4M ago
AVTX
Target downgraded, Salesforce upgraded: Wall Street’s top analyst calls
Premium
The Fly
Target downgraded, Salesforce upgraded: Wall Street’s top analyst calls
5M ago
BJ
PH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >